Expression based biomarkers and models to classify early and late-stage samples of Papillary Thyroid Carcinoma

Cancer statistics, 2019

(2019) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Classification of early and late stage liver hepatocellular carcinoma patients from their genomics and epigenomics profiles

(2019) Harpreet Kaur et al.   PLoS One

TERT mRNA Expression as a Novel Prognostic Marker in Papillary Thyroid Carcinomas

(2019) Aya Tanaka et al.   THYROID

Prediction and Analysis of Skin Cancer Progression using Genomics Profiles of Patients

(2019) Sherry Bhalla et al.   Scientific Reports

Feature specific quantile normalization enables cross-platform classification of molecular subtypes using gene expression data

(2018) Jennifer M Franks et al.   BIOINFORMATICS

Serum interleukin measurement may help identify thyroid cancer patients with active disease

(2018) Mariana Bonjiorno Martins et al.   CLINICAL BIOCHEMISTRY

Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer

(2018) Rengyun Liu et al.   Nature Communications

In Silico Approach for Prediction of Antifungal Peptides

(2018) Piyush Agrawal et al.   Frontiers in Microbiology

AKT activity is elevated in aggressive thyroid neoplasms where it promotes proliferation and invasion

(2017) Daniel R. Matson et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

piggyBacmediates efficient in vivo CRISPR library screening for tumorigenesis in mice

(2017) Chunlong Xu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Gene expression-based biomarkers for discriminating early and late stage of clear cell renal cancer

(2017) Sherry Bhalla et al.   Scientific Reports

A comprehensive genome-wide analysis of long noncoding RNA expression profile in hepatocellular carcinoma

(2017) Hongxia Cui et al.   Cancer Medicine

VDR mRNA overexpression is associated with worse prognostic factors in papillary thyroid carcinoma

(2017) June Young Choi et al.   Endocrine Connections

DUSP5 and DUSP6, two ERK specific phosphatases, are markers of a higher MAPK signaling activation in BRAF mutated thyroid cancers

(2017) Camille Buffet et al.   PLoS One

Role of gene expression profiling in defining indeterminate thyroid nodules in addition toBRAFanalysis

(2016) Nicla Borrelli et al.   CANCER CYTOPATHOLOGY

TERTpromoter mutations in thyroid cancer

(2016) Rengyun Liu et al.   ENDOCRINE-RELATED CANCER

Prognostic markers and response to vandetanib therapy in sporadic medullary thyroid cancer patients

(2016) Vera Tiedje et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Enrichr: a comprehensive gene set enrichment analysis web server 2016 update

(2016) Maxim V. Kuleshov et al.   NUCLEIC ACIDS RESEARCH

Significance of the BRAF mRNA Expression Level in Papillary Thyroid Carcinoma: An Analysis of The Cancer Genome Atlas Data

(2016) Young Jun Chai et al.   PLoS One

Differences in miRNA and mRNA Profile of Papillary Thyroid Cancer Variants

(2016) Tomasz Stokowy et al.   International Journal of Endocrinology

TERT promoter Mutation and Its Association with Clinicopathological Features and Prognosis of Papillary Thyroid Cancer: A Meta-analysis

(2016) Chunping Liu et al.   Scientific Reports

Decorin-mediated inhibition of the migration of U87MG glioma cells involves activation of autophagy and suppression of TGF-β signaling

(2016) Ting Yao et al.   FEBS Open Bio

Association of the Rad9–Rad1–Hus1 checkpoint clamp with MYH DNA glycosylase and DNA

(2015) Bor-Jang Hwang et al.   DNA REPAIR

Identification and Validation of Long Noncoding RNA Biomarkers in Human Non–Small-Cell Lung Carcinomas

(2015) Hui Yu et al.   Journal of Thoracic Oncology

Differential expression profiling of circulation microRNAs in PTC patients with non- 131 I and 131 I-avid lungs metastases: a pilot study

(2015) Zhong-Ling Qiu et al.   NUCLEAR MEDICINE AND BIOLOGY

The Molecular Signatures Database Hallmark Gene Set Collection

(2015) Arthur Liberzon et al.   Cell Systems

Integrated Genomic Characterization of Papillary Thyroid Carcinoma

(2014) Nishant Agrawal et al.   CELL

PRIMA-1, a Mutant p53 Reactivator, Restores the Sensitivity ofTP53Mutant-Type Thyroid Cancer Cells to the Histone Methylation Inhibitor 3-Deazaneplanocin A

(2014) Bo Cui et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

STRING v10: protein–protein interaction networks, integrated over the tree of life

(2014) Damian Szklarczyk et al.   NUCLEIC ACIDS RESEARCH

Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool

(2013) Edward Y Chen et al.   BMC BIOINFORMATICS

RNA Sequencing Identifies Multiple Fusion Transcripts, Differentially Expressed Genes, and Reduced Expression of Immune Function Genes inBRAF(V600E) Mutant vsBRAFWild-Type Papillary Thyroid Carcinoma

(2013) Robert C. Smallridge et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

VIRsiRNApred: a web server for predicting inhibition efficacy of siRNAs targeting human viruses

(2013) Abid Qureshi et al.   Journal of Translational Medicine

CysLT1R Antagonists Inhibit Tumor Growth in a Xenograft Model of Colon Cancer

(2013) Sayeh Savari et al.   PLoS One

A long non-coding RNA, PTCSC3, as a tumor suppressor and a target of miRNAs in thyroid cancer cells

(2013) MIN FAN et al.   Experimental and Therapeutic Medicine

Enhancing electronic nose performance: A novel feature selection approach using dynamic social impact theory and moving window time slicing for classification of Kangra orthodox black tea (Camellia sinensis (L.) O. Kuntze)

(2012) Rishemjit Kaur et al.   SENSORS AND ACTUATORS B-CHEMICAL

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

A novel approach using Dynamic Social Impact Theory for optimization of impedance-Tongue (iTongue)

(2011) Amol P. Bhondekar et al.   CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS

Diagnostic Utility of Galectin-3 in Thyroid Cancer

(2010) Connie G. Chiu et al.   AMERICAN JOURNAL OF PATHOLOGY

Reduced Expression of Reelin (RELN) Gene Is Associated With High Recurrence Rate of Hepatocellular Carcinoma

(2010) Yukiyasu Okamura et al.   ANNALS OF SURGICAL ONCOLOGY

Targeting CREB for Cancer Therapy: Friend or Foe

(2010) X. Xiao et al.   CURRENT CANCER DRUG TARGETS

The impact of using defined criteria for adequacy of fine needle aspiration cytology of the thyroid in routine practice

(2010) Asma S. Haider et al.   DIAGNOSTIC CYTOPATHOLOGY

Molecular Classification of Thyroid Nodules Using High-Dimensionality Genomic Data

(2010) Darya Chudova et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Accurate quantification of transcriptome from RNA-Seq data by effective length normalization

(2010) Soohyun Lee et al.   NUCLEIC ACIDS RESEARCH

Altered antisense-to-sense transcript ratios in breast cancer

(2010) R. Maruyama et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Evolution of Biomarkers in Thyroid Cancer—From Mass Screening to a Personalized Biosignature

(2010) Raymon H. Grogan et al.   Cancers

NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas

(2009) T.-J. Liu et al.   MOLECULAR CANCER THERAPEUTICS

HBME‐1 and CK19 are highly discriminatory in the cytological diagnosis of papillary thyroid carcinoma

(2008) Min‐En Nga et al.   DIAGNOSTIC CYTOPATHOLOGY

Differential Expression of Decorin by Human Malignant and Benign Vascular Tumors

(2008) Henriikka H. Salomäki et al.   JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY